Conrad Asia Energy reports solid progress in Q4 2024 with finalized gas sales agreements and promising LNG studies, despite delayed final investment decisions due to regulatory approvals.
Bioxyne Limited has raised its FY2025 revenue forecast to $25 million, driven by a remarkable 267% increase in first-half revenue and strong momentum from its subsidiary Breathe Life Sciences.
Santana Minerals has reported a robust Pre-feasibility Study for its Bendigo-Ophir Gold Project, lifting the after-tax NPV to A$1.2 billion and IRR to 76%, as it progresses detailed engineering and fast-track permitting in New Zealand.
Cyclopharm has inked a pivotal three-year agreement with HCA Healthcare, enabling deployment of its Technegas® lung imaging technology across up to 169 US nuclear medicine departments. This deal marks a major step in expanding Technegas®’ footprint in the American healthcare market.
Macmahon Holdings has landed a $463 million mining services contract for the Awak Mas gold project in Indonesia, reinforcing its order book and maintaining its FY25 earnings guidance.